Organon & Co. (LON:0A9W)

Organon & Co. Statistics

Total Valuation

Organon & Co. has a market cap or net worth of GBP 1.86 billion. The enterprise value is 8.13 billion.

Market Cap	1.86B
Enterprise Value	8.13B

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	May 12, 2025

Share Statistics

Current Share Class	259.96M
Shares Outstanding	n/a
Shares Change (YoY)	+1.17%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	258.73M

Valuation Ratios

The trailing PE ratio is 3.20 and the forward PE ratio is 2.52.

PE Ratio	3.20
Forward PE	2.52
PS Ratio	0.38
PB Ratio	4.42
P/TBV Ratio	n/a
P/FCF Ratio	3.09
P/OCF Ratio	2.56
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.17, with an EV/FCF ratio of 13.53.

EV / Earnings	14.01
EV / Sales	1.73
EV / EBITDA	6.17
EV / EBIT	7.74
EV / FCF	13.53

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 16.52.

Current Ratio	1.67
Quick Ratio	0.77
Debt / Equity	16.52
Debt / EBITDA	5.07
Debt / FCF	11.53
Interest Coverage	2.74

Financial Efficiency

Return on equity (ROE) is 254.24% and return on invested capital (ROIC) is 9.64%.

Return on Equity (ROE)	254.24%
Return on Assets (ROA)	7.03%
Return on Invested Capital (ROIC)	9.64%
Return on Capital Employed (ROCE)	13.36%
Revenue Per Employee	487,149
Profits Per Employee	58,049
Employee Count	10,000
Asset Turnover	0.50
Inventory Turnover	2.05

Taxes

Income Tax	-60.37M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.65% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-52.65%
50-Day Moving Average	9.45
200-Day Moving Average	13.96
Relative Strength Index (RSI)	44.96
Average Volume (20 Days)	4,048

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.82

Income Statement

In the last 12 months, Organon & Co. had revenue of GBP 4.87 billion and earned 580.49 million in profits. Earnings per share was 2.23.

Revenue	4.87B
Gross Profit	2.79B
Operating Income	1.09B
Pretax Income	520.12M
Net Income	580.49M
EBITDA	1.32B
EBIT	1.09B
Earnings Per Share (EPS)	2.23

Balance Sheet

The company has 423.37 million in cash and 6.93 billion in debt, giving a net cash position of -6.51 billion.

Cash & Cash Equivalents	423.37M
Total Debt	6.93B
Net Cash	-6.51B
Net Cash Per Share	n/a
Equity (Book Value)	419.50M
Book Value Per Share	1.63
Working Capital	1.36B

Cash Flow

In the last 12 months, operating cash flow was 726.00 million and capital expenditures -124.61 million, giving a free cash flow of 601.39 million.

Operating Cash Flow	726.00M
Capital Expenditures	-124.61M
Free Cash Flow	601.39M
FCF Per Share	n/a

Margins

Gross margin is 57.32%, with operating and profit margins of 22.37% and 11.92%.

Gross Margin	57.32%
Operating Margin	22.37%
Pretax Margin	10.68%
Profit Margin	11.92%
EBITDA Margin	27.07%
EBIT Margin	22.37%
FCF Margin	12.35%

Dividends & Yields

This stock pays an annual dividend of 0.67, which amounts to a dividend yield of 6.72%.

Dividend Per Share	0.67
Dividend Yield	6.72%
Dividend Growth (YoY)	-24.65%
Years of Dividend Growth	n/a
Payout Ratio	39.73%
Buyback Yield	-1.17%
Shareholder Yield	5.55%
Earnings Yield	31.28%
FCF Yield	32.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Organon & Co. has an Altman Z-Score of 1.32 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.32
Piotroski F-Score	5